Fen-Phen Suit Asserting Deadly Lung Disease Is Remanded By MDL Court
PHILADELPHIA - The federal judge supervising multidistrict litigation over Wyeth’s diet drugs on Oct. 13 remanded claims that the drugs caused a Nevada woman’s primary pulmonary hypertension (PPH) with at least one dispute unresolved (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Cynthia Righetti v. Wyeth Inc., et al., No. 07-20144, E.D. Pa.; See October 2009, Page 
.
Full story on lexis.com
Original post by LexisNexis® Mealey’sâ„¢ Legal News